{"date":"2025-04-01","count":13,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4198-2025-04-01-1913-1ckq9oo","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-04-01","time":"19:13:16","subject":"代子公司瑞亞生醫公告-董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-04-01 19:13，「代子公司瑞亞生醫公告-董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-04-01-1910-1ovx8z1","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-04-01","time":"19:10:09","subject":"代子公司瑞亞生醫公告-唯一法人股東重新指派董監事代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-04-01 19:10，「代子公司瑞亞生醫公告-唯一法人股東重新指派董監事代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-04-01-1710-uxtqej","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-01","time":"17:10:22","subject":"公告本公司董事會決議發行限制型員工權利新股案","clause":"第9款","fact_date":"2025-04-01","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-04-01 17:10，「公告本公司董事會決議發行限制型員工權利新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-04-01-1709-9b93of","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-01","time":"17:09:40","subject":"公告本公司董事會決議擬辦理私募現金增資發行普通股","clause":"第9款","fact_date":"2025-04-01","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-04-01 17:09，「公告本公司董事會決議擬辦理私募現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-04-01-1709-11hosiy","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-01","time":"17:09:01","subject":"本公司決議不繼續辦理113年度股東常會通過之私募普通股案","clause":"第14款","fact_date":"2025-04-01","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-04-01 17:09，「本公司決議不繼續辦理113年度股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-04-01-1708-kgzfg5","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-01","time":"17:08:21","subject":"公告本公司董事會決議召開114年股東常會事宜(異動召集事由)","clause":"第32款","fact_date":"2025-04-01","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-04-01 17:08，「公告本公司董事會決議召開114年股東常會事宜(異動召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-04-01-1636-1ytk4c4","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-04-01","time":"16:36:49","subject":"公告本公司脂肪肝炎新藥SNP-610取得歐洲專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-04-01 16:36，「公告本公司脂肪肝炎新藥SNP-610取得歐洲專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-04-01-1546-lgf7f3","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-04-01","time":"15:46:11","subject":"本公司OBI-902 TROP2 ADC新藥向美國食品藥物管理局(FDA)提出一/二期人體臨床試驗申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-04-01 15:46，「本公司OBI-902 TROP2 ADC新藥向美國食品藥物管理局(FDA)提出一/二期人體臨床試驗申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-04-01-1535-10thh01","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-04-01","time":"15:35:18","subject":"補充說明更正114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-04-01 15:35，「補充說明更正114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2025-04-01-1530-rmdg54","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2025-04-01","time":"15:30:04","subject":"內部稽核主管異動","clause":"第11款","fact_date":"2025-04-01","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2025-04-01 15:30，「內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-04-01-1437-p67uuk","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-04-01","time":"14:37:37","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-04-01 14:37，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-04-01-1411-54swv6","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-04-01","time":"14:11:02","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-04-01 14:11，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-04-01-0006-1ue78sr","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-04-01","time":"00:06:30","subject":"公告本公司董事會決議不分配113年度董事及員工酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-04-01 00:06，「公告本公司董事會決議不分配113年度董事及員工酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}